Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prosthesis Failure × Doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 245 Lymphoma 169 Lymphoma, Large B-Cell, Diffuse 145 Sarcoma 120 Precursor Cell Lymphoblastic Leukemia-Lymphoma 94 Hodgkin Disease 72 Lymphoma, Non-Hodgkin 66 Burkitt Lymphoma 58 Lymphoma, Follicular 56 Leukemia 51 Ovarian Neoplasms 44 Triple Negative Breast Neoplasms 42 Neoplasms 41 Carcinoma, Hepatocellular 41 Lymphoma, Mantle-Cell 39 Multiple Myeloma 36 Neoplasm Metastasis 34 Neuroblastoma 33 Lymphoma, B-Cell 27 Lymphoma, Large-Cell, Anaplastic 24 Osteosarcoma 22 Lymphoma, Large-Cell, Immunoblastic 21 Urinary Bladder Neoplasms 20 Recurrence 20 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 20 Liposarcoma 20 Leiomyosarcoma 20 Liver Neoplasms 19 HIV Infections 19 Endometrial Neoplasms 18

Interventions

Radiotherapy 1 Paclitaxel 1 Olanzapine 1 Megestrol Acetate 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01918124 2018-10-12

EC-0701

Fudan University

Phase 2 Completed

Prosthesis Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡